Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.

× No keyword cloud information.

19 in total

1. Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.

Authors: Jean-François Dufour; Hanno Hoppe; Markus H Heim; Beat Helbling; Olivier Maurhofer; Zsolt Szucs-Farkas; Ralph Kickuth; Markus Borner; Daniel Candinas; Bettina Saar
Journal: Oncologist Date: 2010-10-29

2. Management of hepatocellular carcinoma: time to be resilient.

Authors: Jean-Francois Dufour
Journal: Hepat Oncol Date: 2014-09-09

3. Design and synthesis of dual-ligand modified chitosan as a liver targeting vector.

Authors: Houxiang Chen; Min Li; Tao Wan; Qichang Zheng; Mingrong Cheng; Shiqi Huang; Yong Wang
Journal: J Mater Sci Mater Med Date: 2011-11-22 Impact factor: 3.896

Review 4. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.

Authors: Tamara Severi; Hannah van Malenstein; Chris Verslype; Jos F van Pelt
Journal: Acta Pharmacol Sin Date: 2010-10-18 Impact factor: 6.150

5. Expression and prognostic potential of TMEM204: a pan-cancer analysis.

Authors: Zicheng Zhen; Minghao Li; Muyan Zhong; Jiaqi Liu; Wendu Huang; Liqun Ye
Journal: Int J Clin Exp Pathol Date: 2022-07-15

6. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.

Authors: Xuanlin Shen; Yuting Ding; Feng Lu; Haitao Yuan; Wenkang Luan
Journal: Am J Transl Res Date: 2020-10-15 Impact factor: 4.060

7. Preparation and evaluation of reduction-responsive nano-micelles for miriplatin delivery.

Authors: Ying Zhang; Dejian Hu; Shangcong Han; Guowen Yan; Chao Ma; Chen Wei; Miao Yu; Dongmei Li; Yong Sun
Journal: Exp Biol Med (Maywood) Date: 2016-01-06

8. Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation.

Authors: Rui-Kun Zhang; Jia-Lin Liu
Journal: BMC Med Genomics Date: 2021-06-19 Impact factor: 3.063

9. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression.

Authors: Xinhua Zou; Wenzhe Fan; Miao Xue; Jiaping Li
Journal: Cancer Manag Res Date: 2021-05-18 Impact factor: 3.989

10. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.

Authors: Tianming Chen; Changhao Zhu; Xing Wang; Yaozhen Pan
Journal: Can J Gastroenterol Hepatol Date: 2021-07-09